## **Core Concept**
The question tests knowledge on the treatment of Methicillin-resistant Staphylococcus aureus (MRSA) infections. MRSA is a type of bacteria that is resistant to many antibiotics, including methicillin and other penicillins and penicillin-like medications. The management of MRSA infections requires specific antibiotics that can effectively target and eliminate the bacteria.

## **Why the Correct Answer is Right**
Vancomycin is considered a drug of choice for treating serious MRSA infections. It is a glycopeptide antibiotic that inhibits cell wall synthesis in bacteria and has been a mainstay in the treatment of MRSA infections for decades. Vancomycin is effective against MRSA and is often used for severe infections such as bacteremia, endocarditis, and pneumonia.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Although not specified, if this option is a penicillin-like antibiotic (e.g., methicillin, oxacillin), it would be incorrect because MRSA is resistant to these types of antibiotics.
- **Option B:** If this option is another antibiotic that is not effective against MRSA (e.g., erythromycin, amoxicillin), it would be incorrect because these antibiotics do not reliably treat MRSA infections.
- **Option D:** If this option is an antibiotic that, while potentially effective against some Gram-positive bacteria, is not a first-line treatment for MRSA (e.g., ciprofloxacin, doxycycline), it would be incorrect because they are not considered drugs of choice for MRSA.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that vancomycin is a drug of choice for MRSA, but its use must be monitored due to potential nephrotoxicity and ototoxicity. Additionally, the emergence of vancomycin-resistant Enterococci (VRE) and concerns about vancomycin-resistant MRSA have made the search for alternative treatments a priority.

## **Correct Answer:** . Vancomycin